Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 16:15 | 11/17/23 | ALVR | Health | BioPrd | Biological Products, (No Diag | Hagen Brett R | MA | O | Chief Ac | 23 | S.m | -50 | 0.8193 | 0 | -61 | 129 | D | |||||||||||||||
11/20/24 16:15 | 11/17/23 | ALVR | Health | BioPrd | Biological Products, (No Diag | Sinha Vikas | MA | DOT | See Rema | 21 | S.m | -91 | 1.10 | 0 | -82 | 0 | 17,859 | D | ||||||||||||||
11/20/24 16:15 | 11/19/24 | ALVR | Health | BioPrd | Biological Products, (No Diag | Miller Edward | MA | O | GC | 16 | S.m | -18 | 0.7261 | 0 | -24 | 524 | D | |||||||||||||||
11/20/24 16:15 | 11/17/23 | ALVR | Health | BioPrd | Biological Products, (No Diag | Brainard Diana | MA | DO | CEO | 23 | S.m | -207 | 1.08 | 0 | -192 | 907 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |